- Report
- August 2024
- 85 Pages
India
From €3327EUR$3,500USD£2,795GBP
- Report
- June 2024
- 80 Pages
Egypt
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2023
- 148 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2022
- 140 Pages
Global
€2852EUR$3,000USD£2,396GBP
- Book
- December 2024
- 592 Pages
The Counterfeit Drug market is a major issue within the Pharmaceuticals industry. Counterfeit drugs are fake or unapproved versions of legitimate drugs, often made with inferior or dangerous ingredients. These drugs are often sold at a lower price than the legitimate versions, making them attractive to consumers. Counterfeit drugs can be found in both developed and developing countries, and are often sold online or through illegal channels.
Counterfeit drugs can have serious health consequences, including death, and can also lead to a decrease in public trust in the pharmaceutical industry. To combat this issue, governments and pharmaceutical companies have implemented various measures, such as increased regulation and improved supply chain security.
Some companies in the Counterfeit Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and Johnson & Johnson. Show Less Read more